hpv16 positive human cervical cancer cell line caski Search Results


94
Sino Biological hpv type 16 l1 protein standard
Hpv Type 16 L1 Protein Standard, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/Human+Papilloma+Virus+type+16+(HPV+16)+L1+protein/10__26434_slash_chemrxiv___2024___z9ls1-63-0-9
Average 94 stars, based on 1 article reviews
hpv type 16 l1 protein standard - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

99
New England Biolabs pbr322 hpv 16 plasmid
Pbr322 Hpv 16 Plasmid, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/BamHI/pmc06403315__41598_2019_40094_MOESM1_ESM-26-15-37
Average 99 stars, based on 1 article reviews
pbr322 hpv 16 plasmid - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology hpv 16 18 e6 detection
Hpv 16 18 E6 Detection, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/HPV16+E6+(hpv)-PR/10__3892_slash_or_00000192-57-1-30
Average 93 stars, based on 1 article reviews
hpv 16 18 e6 detection - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

caski  (ATCC)
97
ATCC caski
The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis <t>of</t> <t>HPV-positive</t> cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, <t>CaSki,</t> and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.
Caski, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/Ca+Ski/pmc08750593-58-3-35
Average 97 stars, based on 1 article reviews
caski - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

siha  (ATCC)
98
ATCC siha
The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis <t>of</t> <t>HPV-positive</t> cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, <t>CaSki,</t> and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.
Siha, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/SiHa/pm28647699-42-3-16
Average 98 stars, based on 1 article reviews
siha - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

90
EyeGene Inc hpv-16 l1 virus-like particle vlp
The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis <t>of</t> <t>HPV-positive</t> cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, <t>CaSki,</t> and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.
Hpv 16 L1 Virus Like Particle Vlp, supplied by EyeGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/hpv+16+l1+virus+like+particle+vlp/pmc05334157-105-0-19
Average 90 stars, based on 1 article reviews
hpv-16 l1 virus-like particle vlp - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
ImmunoGen Inc hpv-16 vlps
The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis <t>of</t> <t>HPV-positive</t> cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, <t>CaSki,</t> and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.
Hpv 16 Vlps, supplied by ImmunoGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/hpv16+l2+1+88/pmc01782473-105-57-32
Average 90 stars, based on 1 article reviews
hpv-16 vlps - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

93
ATCC hpv 16 e6 e7
The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis <t>of</t> <t>HPV-positive</t> cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, <t>CaSki,</t> and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.
Hpv 16 E6 E7, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/E7/pmc04883781-26-17-24
Average 93 stars, based on 1 article reviews
hpv 16 e6 e7 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
Genosphere g15f peptide from the hpv-16 e7 protein
The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis <t>of</t> <t>HPV-positive</t> cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, <t>CaSki,</t> and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.
G15f Peptide From The Hpv 16 E7 Protein, supplied by Genosphere, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/200%C2%B5g+g15f+peptide+from+the+hpv+16+e7+protein/pm39953623-47-10-13
Average 90 stars, based on 1 article reviews
g15f peptide from the hpv-16 e7 protein - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

88
Santa Cruz Biotechnology hpv 16 e1 e4
The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis <t>of</t> <t>HPV-positive</t> cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, <t>CaSki,</t> and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.
Hpv 16 E1 E4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/HPV16+E1%2FE4+Antibody/pmc02914195-302-24-12
Average 88 stars, based on 1 article reviews
hpv 16 e1 e4 - by Bioz Stars, 2026-10
88/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology hpv 16 e7
The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis <t>of</t> <t>HPV-positive</t> cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, <t>CaSki,</t> and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.
Hpv 16 E7, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/HPV16+E7+(hpv)-PR/10__1128_slash_jvi__00881___07-80-3-6
Average 93 stars, based on 1 article reviews
hpv 16 e7 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
PrimerDesign Inc genesig kit for human papillomavirus 16 y 18
The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis <t>of</t> <t>HPV-positive</t> cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, <t>CaSki,</t> and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.
Genesig Kit For Human Papillomavirus 16 Y 18, supplied by PrimerDesign Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv16+positive+human+cervical+cancer+cell+line+caski/genesig+kit+for+human+papillomavirus+16+y+18/pmc09587888-73-28-23
Average 90 stars, based on 1 article reviews
genesig kit for human papillomavirus 16 y 18 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis of HPV-positive cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, CaSki, and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.

Journal: Cancers

Article Title: Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells

doi: 10.3390/cancers14010193

Figure Lengend Snippet: The cell-cycle arrest induced by Cpd12 occurs in the G1 phase. ( A ) The effects of Cpd12, the inactive small molecule Cpd3, or DMSO, on cell cycle modulation were evaluated by cytofluorimetric analysis of HPV-positive cervical (ME180 and MS751) and head-and-neck (SCC152) cancer cells treated for 24 h and then stained with PI. Bar graphs represent the percentage of cells in the different phases of the cell cycle (G0/G1, M, G2/S) as the mean of three independent experiments. ( B ) Cell-cycle distributions of HPV-positive cervical (ME180, MS751, HeLa, CaSki, and SiHa) and head-and-neck (SCC152) cancer cells treated with Cpd12 (50 µM) or DMSO for 24 h were determined through immunofluorescence assays. Cells in either the G0, G1, S, G2, or M phase were determined as a function of Ki67 and nuclear staining, and fluorescence intensities were quantified from maximum intensity projections of Z-stack images acquired with a 600× magnification. Total numbers of cells were: n DMSO = 463 and n Cpd12 = 304 for ME180 cells, n DMSO = 303 and n Cpd12 = 316 for MS751 cells, n DMSO = 314 and n Cpd12 = 267 for SCC152 cells, n DMSO = 303 and n Cpd12 = 270 for HeLa cells, n DMSO = 388 and n Cpd12 = 330 for CaSki cells, and n DMSO = 336 and n Cpd12 = 244 for SiHa cells. Nuclei were stained with DRAQ5. 2N: diploid DNA content, 4N: tetraploid DNA content.

Article Snippet: HPV-positive HeLa (HPV18), CaSki (HPV16), SiHa (HPV16), ME180 (HPV68), MS751 (HPV45), and HPV-negative C33A cervical cancer cells, HPV-positive SCC152 (HPV16) and HPV-negative FaDu head-and-neck cancer cells, and human foreskin fibroblasts (HFF) were all from the American Type Culture Collection (ATCC, Manassas, VA, USA).

Techniques: Staining, Immunofluorescence, Fluorescence

The Cpd12-induced rescue of p53 affects the migration capacity of HPV-transformed cells. ( A ) Confluent monolayers of HeLa, CaSki, and ME180 cervical cancer cells were scraped up two times and then treated with increasing concentration of Cpd12 (10, 25, and 50 µM) in low serum medium. The wound closure was monitored before treatment and after 12, 24, and 48 h, and representative images were taken using a bright-field inverted microscope (100× magnification). ( B ) HeLa cells were treated with Cpd12 (50 μM) for 24 h. Then, cell migration was evaluated by transwell assays after an incubation of other 24 h in Cpd12-free medium. Representative images of migrated cells fixed and colored with crystal violet were taken using a bright-field inverted microscope (100× magnification). In both panels, cells treated with DMSO or Cpd3 (50 μM) were included as negative controls.

Journal: Cancers

Article Title: Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells

doi: 10.3390/cancers14010193

Figure Lengend Snippet: The Cpd12-induced rescue of p53 affects the migration capacity of HPV-transformed cells. ( A ) Confluent monolayers of HeLa, CaSki, and ME180 cervical cancer cells were scraped up two times and then treated with increasing concentration of Cpd12 (10, 25, and 50 µM) in low serum medium. The wound closure was monitored before treatment and after 12, 24, and 48 h, and representative images were taken using a bright-field inverted microscope (100× magnification). ( B ) HeLa cells were treated with Cpd12 (50 μM) for 24 h. Then, cell migration was evaluated by transwell assays after an incubation of other 24 h in Cpd12-free medium. Representative images of migrated cells fixed and colored with crystal violet were taken using a bright-field inverted microscope (100× magnification). In both panels, cells treated with DMSO or Cpd3 (50 μM) were included as negative controls.

Article Snippet: HPV-positive HeLa (HPV18), CaSki (HPV16), SiHa (HPV16), ME180 (HPV68), MS751 (HPV45), and HPV-negative C33A cervical cancer cells, HPV-positive SCC152 (HPV16) and HPV-negative FaDu head-and-neck cancer cells, and human foreskin fibroblasts (HFF) were all from the American Type Culture Collection (ATCC, Manassas, VA, USA).

Techniques: Migration, Transformation Assay, Concentration Assay, Inverted Microscopy, Incubation

Analysis of the effect of the drug combination on HPV-positive cervical and head-and-neck cancer cells viability.

Journal: Cancers

Article Title: Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells

doi: 10.3390/cancers14010193

Figure Lengend Snippet: Analysis of the effect of the drug combination on HPV-positive cervical and head-and-neck cancer cells viability.

Article Snippet: HPV-positive HeLa (HPV18), CaSki (HPV16), SiHa (HPV16), ME180 (HPV68), MS751 (HPV45), and HPV-negative C33A cervical cancer cells, HPV-positive SCC152 (HPV16) and HPV-negative FaDu head-and-neck cancer cells, and human foreskin fibroblasts (HFF) were all from the American Type Culture Collection (ATCC, Manassas, VA, USA).

Techniques: